Key Details
Annual ROE
-80.88%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Nov 10, 2023Recent annual earnings:
Mar 20, 2023Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
21 Aug '23 HC Wainwright & Co.
Buy01 May '23 Barclays
Overweight21 Mar '23 HC Wainwright & Co.
Buy25 Oct '22 Barclays
Overweight23 Dec '21 HC Wainwright & Co.
Buy24 Sept '21 Cantor Fitzgerald
Overweight17 Mar '21 RBC Capital
Outperform10 July '20 SunTrust Robinson Humphrey
Buy10 July '20 SVB Leerink
Outperform06 Mar '20 SVB Leerink
OutperformScreeners with RVLP included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
RVL Pharmaceuticals doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
Why Is RVL Pharmaceuticals (RVLP) Stock Up 40% Today?
RVLP
InvestorPlace18 October 2023
RVL Pharmaceuticals (NASDAQ: RVLP ) stock is rising higher on Wednesday even without any news from the specialty pharmaceutical company. Shares of RVL Pharmaceuticals stock are climbing today despite the company not putting out any new press releases.
Why Is RVL Pharmaceuticals (RVLP) Stock Up 28% Today?
RVLP
InvestorPlace06 October 2023
RVL Pharmaceuticals (NASDAQ: RVLP ) stock is climbing higher on Friday despite a lack of news from the specialty pharmaceutical company. There aren't any new press releases of filings with the Securities and Exchange Commission (SEC) that explain why the shares are up today.
RVL Pharmaceuticals plc to Present at the H.C. Wainwright 25th Annual Global Investment Conference
RVLP
GlobeNewsWire23 August 2023
BRIDGEWATER, N.J., Aug. 23, 2023 (GLOBE NEWSWIRE) -- RVL Pharmaceuticals plc (Nasdaq: RVLP) (“RVL” or the “Company”), a specialty pharmaceutical company, today announced that Brian Markison, Chief Executive Officer, will participate in a fireside chat and host 1x1 investor meetings at the H.C. Wainwright 25 th Annual Global Investment Conference in New York City as follows:
FAQ
- What is the primary business of RVL Pharmaceuticals?
- What is the ticker symbol for RVL Pharmaceuticals?
- Does RVL Pharmaceuticals pay dividends?
- What sector is RVL Pharmaceuticals in?
- What industry is RVL Pharmaceuticals in?
- What country is RVL Pharmaceuticals based in?
- When did RVL Pharmaceuticals go public?
- Is RVL Pharmaceuticals in the S&P 500?
- Is RVL Pharmaceuticals in the NASDAQ 100?
- Is RVL Pharmaceuticals in the Dow Jones?
- When was RVL Pharmaceuticals's last earnings report?
- When does RVL Pharmaceuticals report earnings?
- Should I buy RVL Pharmaceuticals stock now?
What is the primary business of RVL Pharmaceuticals?
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. It is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January 2022. RVL Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.
What is the ticker symbol for RVL Pharmaceuticals?
The ticker symbol for RVL Pharmaceuticals is NASDAQ:RVLP
Does RVL Pharmaceuticals pay dividends?
No, RVL Pharmaceuticals does not pay dividends
What sector is RVL Pharmaceuticals in?
RVL Pharmaceuticals is in the Healthcare sector
What industry is RVL Pharmaceuticals in?
RVL Pharmaceuticals is in the Biotechnology industry
What country is RVL Pharmaceuticals based in?
RVL Pharmaceuticals is headquartered in United States
When did RVL Pharmaceuticals go public?
RVL Pharmaceuticals's initial public offering (IPO) was on 19 October 2018
Is RVL Pharmaceuticals in the S&P 500?
No, RVL Pharmaceuticals is not included in the S&P 500 index
Is RVL Pharmaceuticals in the NASDAQ 100?
No, RVL Pharmaceuticals is not included in the NASDAQ 100 index
Is RVL Pharmaceuticals in the Dow Jones?
No, RVL Pharmaceuticals is not included in the Dow Jones index
When was RVL Pharmaceuticals's last earnings report?
RVL Pharmaceuticals's most recent earnings report was on 10 November 2023
When does RVL Pharmaceuticals report earnings?
The date for RVL Pharmaceuticals's next earnings report has not been announced yet
Should I buy RVL Pharmaceuticals stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions